| . | In-hospital . | 30-day follow-up . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Prior to BENCHMARK . | BENCHMARK . | . | Prior to BENCHMARK . | BENCHMARK . | . | ||||
| . | N . | n (%) . | N . | n (%) . | P-value . | N . | n (%) . | N . | n (%) . | P-value . |
| All-cause mortality | 896 | 2 (0.2) | 1460 | 7 (0.5) | .497 | 816 | 4 (0.5) | 1230 | 9 (0.6) | .500 |
| TAVI related | 2 | 4 | 2 | 4 | ||||||
| Cardiac, not TAVI related | 0 | 3 | 0 | 3 | ||||||
| Non-cardiac | 0 | 0 | 2 | 2 | ||||||
| Stroke/TIA | 895 | 7 (0.8) | 1453 | 13 (0.9) | .773 | 808 | 10 (1.2) | 1311 | 18 (1.4) | .791 |
| Life-threatening bleeding | 894 | 10 (1.1) | 1453 | 13 (0.9) | .593 | 809 | 11 (1.4) | 1307 | 16 (1.2) | .782 |
| AKI (stage 2/3, incl. dialysis) | 894 | 2 (0.2) | 1453 | 9 (0.6) | .173 | 808 | 4 (0.5) | 1306 | 10 (0.8) | .456 |
| Coronary artery obstruction requiring intervention | 895 | 3 (0.3) | 1453 | 3 (0.2) | .548 | 803 | 5 (0.6) | 1305 | 5 (0.4) | .443 |
| Major vascular complication | 895 | 29 (3.2) | 1453 | 26 (1.8) | .024 | 812 | 32 (3.9) | 1308 | 26 (2.0) | .007 |
| Permanent pacemaker | 897 | 155 (17.3) | 1473 | 195 (13.2) | .007 | 897 | 171 (19.1) | 1473 | 206 (14.0) | .001 |
| Re-hospitalizationa | ||||||||||
| Valve-related symptoms or worsening CHF | 809 | 12 (1.5) | 1305 | 14 (1.1) | .405 | |||||
| Other reasons | 809 | 44 (5.4) | 1305 | 55 (4.2) | .195 | |||||
| . | In-hospital . | 30-day follow-up . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Prior to BENCHMARK . | BENCHMARK . | . | Prior to BENCHMARK . | BENCHMARK . | . | ||||
| . | N . | n (%) . | N . | n (%) . | P-value . | N . | n (%) . | N . | n (%) . | P-value . |
| All-cause mortality | 896 | 2 (0.2) | 1460 | 7 (0.5) | .497 | 816 | 4 (0.5) | 1230 | 9 (0.6) | .500 |
| TAVI related | 2 | 4 | 2 | 4 | ||||||
| Cardiac, not TAVI related | 0 | 3 | 0 | 3 | ||||||
| Non-cardiac | 0 | 0 | 2 | 2 | ||||||
| Stroke/TIA | 895 | 7 (0.8) | 1453 | 13 (0.9) | .773 | 808 | 10 (1.2) | 1311 | 18 (1.4) | .791 |
| Life-threatening bleeding | 894 | 10 (1.1) | 1453 | 13 (0.9) | .593 | 809 | 11 (1.4) | 1307 | 16 (1.2) | .782 |
| AKI (stage 2/3, incl. dialysis) | 894 | 2 (0.2) | 1453 | 9 (0.6) | .173 | 808 | 4 (0.5) | 1306 | 10 (0.8) | .456 |
| Coronary artery obstruction requiring intervention | 895 | 3 (0.3) | 1453 | 3 (0.2) | .548 | 803 | 5 (0.6) | 1305 | 5 (0.4) | .443 |
| Major vascular complication | 895 | 29 (3.2) | 1453 | 26 (1.8) | .024 | 812 | 32 (3.9) | 1308 | 26 (2.0) | .007 |
| Permanent pacemaker | 897 | 155 (17.3) | 1473 | 195 (13.2) | .007 | 897 | 171 (19.1) | 1473 | 206 (14.0) | .001 |
| Re-hospitalizationa | ||||||||||
| Valve-related symptoms or worsening CHF | 809 | 12 (1.5) | 1305 | 14 (1.1) | .405 | |||||
| Other reasons | 809 | 44 (5.4) | 1305 | 55 (4.2) | .195 | |||||
TAVI, transcatheter aortic valve implantation; TIA, transient ischaemic attack; AKI, acute kidney injury; CHF, congestive heart failure.
aNot applicable at discharge.
| . | In-hospital . | 30-day follow-up . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Prior to BENCHMARK . | BENCHMARK . | . | Prior to BENCHMARK . | BENCHMARK . | . | ||||
| . | N . | n (%) . | N . | n (%) . | P-value . | N . | n (%) . | N . | n (%) . | P-value . |
| All-cause mortality | 896 | 2 (0.2) | 1460 | 7 (0.5) | .497 | 816 | 4 (0.5) | 1230 | 9 (0.6) | .500 |
| TAVI related | 2 | 4 | 2 | 4 | ||||||
| Cardiac, not TAVI related | 0 | 3 | 0 | 3 | ||||||
| Non-cardiac | 0 | 0 | 2 | 2 | ||||||
| Stroke/TIA | 895 | 7 (0.8) | 1453 | 13 (0.9) | .773 | 808 | 10 (1.2) | 1311 | 18 (1.4) | .791 |
| Life-threatening bleeding | 894 | 10 (1.1) | 1453 | 13 (0.9) | .593 | 809 | 11 (1.4) | 1307 | 16 (1.2) | .782 |
| AKI (stage 2/3, incl. dialysis) | 894 | 2 (0.2) | 1453 | 9 (0.6) | .173 | 808 | 4 (0.5) | 1306 | 10 (0.8) | .456 |
| Coronary artery obstruction requiring intervention | 895 | 3 (0.3) | 1453 | 3 (0.2) | .548 | 803 | 5 (0.6) | 1305 | 5 (0.4) | .443 |
| Major vascular complication | 895 | 29 (3.2) | 1453 | 26 (1.8) | .024 | 812 | 32 (3.9) | 1308 | 26 (2.0) | .007 |
| Permanent pacemaker | 897 | 155 (17.3) | 1473 | 195 (13.2) | .007 | 897 | 171 (19.1) | 1473 | 206 (14.0) | .001 |
| Re-hospitalizationa | ||||||||||
| Valve-related symptoms or worsening CHF | 809 | 12 (1.5) | 1305 | 14 (1.1) | .405 | |||||
| Other reasons | 809 | 44 (5.4) | 1305 | 55 (4.2) | .195 | |||||
| . | In-hospital . | 30-day follow-up . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Prior to BENCHMARK . | BENCHMARK . | . | Prior to BENCHMARK . | BENCHMARK . | . | ||||
| . | N . | n (%) . | N . | n (%) . | P-value . | N . | n (%) . | N . | n (%) . | P-value . |
| All-cause mortality | 896 | 2 (0.2) | 1460 | 7 (0.5) | .497 | 816 | 4 (0.5) | 1230 | 9 (0.6) | .500 |
| TAVI related | 2 | 4 | 2 | 4 | ||||||
| Cardiac, not TAVI related | 0 | 3 | 0 | 3 | ||||||
| Non-cardiac | 0 | 0 | 2 | 2 | ||||||
| Stroke/TIA | 895 | 7 (0.8) | 1453 | 13 (0.9) | .773 | 808 | 10 (1.2) | 1311 | 18 (1.4) | .791 |
| Life-threatening bleeding | 894 | 10 (1.1) | 1453 | 13 (0.9) | .593 | 809 | 11 (1.4) | 1307 | 16 (1.2) | .782 |
| AKI (stage 2/3, incl. dialysis) | 894 | 2 (0.2) | 1453 | 9 (0.6) | .173 | 808 | 4 (0.5) | 1306 | 10 (0.8) | .456 |
| Coronary artery obstruction requiring intervention | 895 | 3 (0.3) | 1453 | 3 (0.2) | .548 | 803 | 5 (0.6) | 1305 | 5 (0.4) | .443 |
| Major vascular complication | 895 | 29 (3.2) | 1453 | 26 (1.8) | .024 | 812 | 32 (3.9) | 1308 | 26 (2.0) | .007 |
| Permanent pacemaker | 897 | 155 (17.3) | 1473 | 195 (13.2) | .007 | 897 | 171 (19.1) | 1473 | 206 (14.0) | .001 |
| Re-hospitalizationa | ||||||||||
| Valve-related symptoms or worsening CHF | 809 | 12 (1.5) | 1305 | 14 (1.1) | .405 | |||||
| Other reasons | 809 | 44 (5.4) | 1305 | 55 (4.2) | .195 | |||||
TAVI, transcatheter aortic valve implantation; TIA, transient ischaemic attack; AKI, acute kidney injury; CHF, congestive heart failure.
aNot applicable at discharge.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
